West Pharma (WST) Misses Q1 EPS by 2c, Beats on Revenues; Offers FY18 EPS/Revenue Mid-Point Outlooks Above Consenus
Go back to West Pharma (WST) Misses Q1 EPS by 2c, Beats on Revenues; Offers FY18 EPS/Revenue Mid-Point Outlooks Above Consenus| WEST PHARMACEUTICAL SERVICES, Inc. (NYSE: WST) | Delayed: 349.42 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $349.42 | 52 Week High | $84.33 | |||
| Open | $349.42 | 52 Week Low | $53.88 | |||
| Day High | $349.42 | P/E | 222.56 | |||
| Day Low | $349.42 | EPS | $1.57 | |||
| Volume | 87 | |||||
